Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsClinicalTrials.gov · 2026-07-01Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.Schizophrenia research · 2026-06-01Management of obsessive-compulsive disorder in adults.BMJ (Clinical research ed.) · 2026-02-16Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01Sudden Loss of Consciousness Following Psilocybin Ingestion.The American journal of psychiatry · 2025-12-01Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic SeizuresClinicalTrials.gov · 2025-08-21Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.Cureus · 2025-08-01Is there mush-room to improve the environmental sustainability of psilocybin production?Journal of CO2 Utilization · 2025-06-1013. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09Psilocybin in Alcohol Use Disorder With Comorbid DepressionClinicalTrials.gov · 2025-03-19Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.JAMA network open · 2024-12-02Distinct classes of antidepressants commonly act to shape pallidal structure and function in micebioRxiv · 2024-09-24Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distressResearch Square · 2024-09-18WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male miceJournal of Hepatology · 2024-05-31Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.Frontiers in psychiatry · 2024-01-01Domestication through clandestine cultivation constrained genetic diversity in magic mushrooms relative to naturalized populations.Current biology: CB · 2023-12-04ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study DesignNeuromodulation Technology at the Neural Interface · 2023-06-01118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-10Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-05Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway.Fungal genetics and biology: FG & B · 2023-03-01The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Use of Selective Alternative Therapies for Treatment of OCD.Neuropsychiatric disease and treatment · 2023-01-01The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of psychopharmacology (Oxford, England) · 2022-01-01Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.Drug and alcohol dependence · 2021-04-01Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in psychiatry · 2021-01-01Effects of psilocin on the striatal monoamine contents in mice and ratsThe Pharmaceutical Society of Japan · 2020-02-01MAGIC MUSHROOMS: from sacred entheogen to Class A drugEntertainment and Sports Law Journal · 2016-06-26Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.Journal of psychopharmacology (Oxford, England) · 2014-01-01Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of clinical psychiatry · 2006-11-01